K2 HealthVentures Launches New Investment Company with Industry-Leading Team and $400 Million Initial Capital Commitment
BOSTON--(BUSINESS WIRE)--May 21, 2019--
K2 HealthVentures (K2HV) announced today the launch of a new specialty finance company that will provide long-term debt, equity, and intellectual capital to private and public life sciences and healthcare companies. With substantial initial funding and a permanent capital base, which is expected to grow significantly over time, the firm will initially target investments ranging in size from $10-50 million. A key principle of K2HV’s charter is its commitment to devoting a portion of investment profits to fund underserved and underinvested areas in the healthcare space, both in the US and globally.
With offices in Boston and New York, the K2HV investment team brings together a unique combination of debt and equity investment expertise, industry experience, and domain knowledge, along with a deep understanding of the needs of innovative life sciences and healthcare companies throughout their lifecycles. This diverse perspective and relevant experience, coupled with strong networks and industry connections, make K2HV an ideal long-term capital partner, as well as a valued advisor on financing and growth strategies. The founding leadership team has a substantial and successful track record in venture and growth stage debt and equity investing, having committed over $2.5 billion to over 100 companies in the life sciences and healthcare space.
Announcing the launch of K2 HealthVentures, Parag Shah, Founding Managing Director and CEO said, “We aim to provide more than capital for life sciences and healthcare companies. We believe that for growing companies to reach the next level, they need patient financial support, proven business expertise, and a funding partner that understands value and risk in this specialized space. K2HV embodies these principles. And like the companies with which we hope to partner, we are driven by both profit and purpose.”
K2 HealthVentures is backed by L1 Health, an international investment firm with extensive experience in healthcare. Commenting on the launch, L1 Health Partner and K2HV Founder and Board Chair Meghan FitzGerald said, “The decision to back an industry-leading team to take this venture forward was timely, as we believe the market need is ripe and growing for creative financing to accelerate innovation in healthcare. With substantial, long-term funding and some smart thinking around science and technology innovation, we hope to improve the lives of millions of patients.”
Founding Managing Director and CIO Anup Arora added, “L1 Health is an ideal partner for us given their long-term investment focus and deep experience in the healthcare space. Importantly, K2HV has patient, permanent capital – with no fixed investment time horizons and no fund cycles. This enables us to be truly long-term oriented and strategic in our approach, and to adapt and grow our investments over time as our partner companies grow.”
K2HV’s primary focus will be on customized debt financing, enabling innovative companies to minimize equity dilution as they reach key lifecycle milestones and build enterprise value. In addition, the firm also has the ability to invest equity capital, thereby aligning its long-term interests with those of its venture and public equity investment partners. K2HV’s permanent capital, flexible approach, and ability to invest across the balance sheet will confer a strong competitive advantage, both for the firm and for its partner companies.
About K2 HealthVentures
K2 HealthVentures is an alternative investment firm focused on providing flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries. The investment team is comprised of collaborative, experienced professionals with diverse backgrounds in finance and operations, as well as deep domain knowledge across various healthcare sectors. A uniquely flexible, permanent capital structure enables the firm to provide creative, adaptive financing solutions and meet the evolving capital needs of its portfolio companies as they grow. K2HV is driven by dual goals of Profit and Purpose – aiming to fuel the growth of innovative companies that will ultimately improve the lives of patients and giving a percentage of investment profits back to underserved areas in healthcare. www.k2hv.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190521005320/en/
CONTACT: K2 HealthVentures
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PROFESSIONAL SERVICES BANKING FINANCE RESEARCH OTHER SCIENCE SCIENCE GENERAL HEALTH
SOURCE: K2 HealthVentures
Copyright Business Wire 2019.
PUB: 05/21/2019 08:00 AM/DISC: 05/21/2019 08:01 AM